The Effect of Disease Modifying Treatment In Multiple Sclerosis Patients

Video

At AAN 2017, Robert Zivadinov, MD, PhD, Professor of neurology, University at Buffalo, discussed the primary findings in the phase 3 randomized, placebo controlled TOPIC study, which focused really on the differences between the two doses (7 and 14mg) of Aubagio and placebo.


Recent Videos
Sorana Segal-Maurer, MD, an expert on HIV
Brendon Neuen, MBBS, PhD | Credit: X.com
Sorana Segal-Maurer, MD, an expert on HIV
Sorana Segal-Maurer, MD, an expert on HIV
Sorana Segal-Maurer, MD, an expert on HIV
Sorana Segal-Maurer, MD, an expert on HIV
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Shauna Applin, ARNP, an expert on HIV
Shauna Applin, ARNP, an expert on HIV
Shauna Applin, ARNP, an expert on HIV
© 2024 MJH Life Sciences

All rights reserved.